Assessment of the Monocyte Subpopulations and M1/M2 Macrophage Ratio in Concentrated Bone Marrow Aspirate

Overview

Journal Cartilage

Date 2024 Dec 9

PMID 39651680

Authors

James J Butler

John F Dankert

Laura E Keller

Mohammad T Azam

Jari Dahmen

Gino M M J Kerkhoffs

John G Kennedy

Affiliations

Soon will be listed here.

Abstract

Objective: The purpose of this study was to determine the M1/M2 macrophage ratio in concentrated bone marrow aspirate (cBMA) in patients undergoing surgical intervention augmented with cBMA for osteochondral lesions of the talus (OLTs).

Design: Samples of peripheral blood (PB), bone marrow aspirate (BMA), and cBMA were collected during the procedure. The samples were analyzed by automated cell counting and multicolor fluorescence-activated cell sorting with specific antibodies recognizing monocytes (CD14+ CD16+) and the M1 (CD86+) and M2 (CD163+CD206+) populations within that monocyte population. Cytokine concentrations within the samples were evaluated with enzyme-linked immunosorbent assay (ELISA). The composition of cBMA was compared between 2 commercially available BMA concentration systems.

Results: Thirty-eight patients with a mean age of 43.2 ± 10.1 years old undergoing a surgical procedure for the treatment of OLTs involving the use of cBMA were included. cBMA had a mean fold increase of 4.7 for all white blood cells, 6.1 for monocytes, 7.9 for lymphocytes, 2.4 for neutrophils, and 9.6 for platelets when compared to BMA. The mean M1/M2 ratio for PB, BMA, and cBMA was 15.2 ± 12.0, 20.8 ± 13.3, and 22.1 ± 16.0, respectively. There was a statistically significant higher concentration of interleukin-1 receptor antagonist (IL-1Ra) in the cBMA sample (8243.3 ± 14,837.4 pg/mL) compared to both BMA (3143.0 ± 2218.5 pg/mL) and PB (1847.5 ± 1520.4 pg/mL) samples. The IL-1Ra/IL-1β ratio for PB, BMA, and cBMA was 790.6 ± 581.9, 764.7 ± 675.2, and 235.7 ± 192.1, respectively. There was no difference in the cBMA M1/M2 ratio (19.0 ± 11.1 vs 24.0 ± 18.3) between the Magellan (Isto Biologics, Hopkinton, Massachusetts) and Angel systems (Arthrex Inc, Naples, Florida).

Conclusion: This prospective study found that the M1/M2 ratio in cBMA was 22.1 ± 16.0, with significant patient to patient variation observed. Overall, there was no statistically significant difference in the M1/M2 ratio across PB, BMA, and cBMA samples. This is the first study to characterize the macrophage subpopulation within cBMA, which may have significant clinical implications in future studies.

References

Locati M, Curtale G, Mantovani A . Diversity, Mechanisms, and Significance of Macrophage Plasticity. Annu Rev Pathol. 2019; 15:123-147. PMC: 7176483. DOI: 10.1146/annurev-pathmechdis-012418-012718. View

Gaul F, Bugbee W, Hoenecke Jr H, DLima D . A Review of Commercially Available Point-of-Care Devices to Concentrate Bone Marrow for the Treatment of Osteoarthritis and Focal Cartilage Lesions. Cartilage. 2018; 10(4):387-394. PMC: 6755874. DOI: 10.1177/1947603518768080. View

Liu B, Zhang M, Zhao J, Zheng M, Yang H . Imbalance of M1/M2 macrophages is linked to severity level of knee osteoarthritis. Exp Ther Med. 2018; 16(6):5009-5014. PMC: 6256852. DOI: 10.3892/etm.2018.6852. View

Adams S, Giza E, Brigido S, Cooper M . Osteochondral Lesions of the Ankle. Foot Ankle Spec. 2017; 10(5):455-457. DOI: 10.1177/1938640017730166. View

Balusani Jr P, Shrivastava S, Pundkar A, Kale P . Navigating the Therapeutic Landscape: A Comprehensive Review of Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate in Knee Osteoarthritis. Cureus. 2024; 16(2):e54747. PMC: 10960965. DOI: 10.7759/cureus.54747. View

Dragoo J, Guzman R . Evaluation of the Consistency and Composition of Commercially Available Bone Marrow Aspirate Concentrate Systems. Orthop J Sports Med. 2020; 8(1):2325967119893634. PMC: 6970477. DOI: 10.1177/2325967119893634. View

Li M, Yin H, Yan Z, Li H, Wu J, Wang Y . The immune microenvironment in cartilage injury and repair. Acta Biomater. 2021; 140:23-42. DOI: 10.1016/j.actbio.2021.12.006. View

Fukui S, Iwamoto N, Takatani A, Igawa T, Shimizu T, Umeda M . M1 and M2 Monocytes in Rheumatoid Arthritis: A Contribution of Imbalance of M1/M2 Monocytes to Osteoclastogenesis. Front Immunol. 2018; 8:1958. PMC: 5766997. DOI: 10.3389/fimmu.2017.01958. View

Cassano J, Kennedy J, Ross K, Fraser E, Goodale M, Fortier L . Bone marrow concentrate and platelet-rich plasma differ in cell distribution and interleukin 1 receptor antagonist protein concentration. Knee Surg Sports Traumatol Arthrosc. 2016; 26(1):333-342. DOI: 10.1007/s00167-016-3981-9. View

10.

Fernandes T, Gomoll A, Lattermann C, Hernandez A, Bueno D, Amano M . Macrophage: A Potential Target on Cartilage Regeneration. Front Immunol. 2020; 11:111. PMC: 7026000. DOI: 10.3389/fimmu.2020.00111. View

11.

Arend W, Guthridge C . Biological role of interleukin 1 receptor antagonist isoforms. Ann Rheum Dis. 2000; 59 Suppl 1:i60-4. PMC: 1766634. DOI: 10.1136/ard.59.suppl_1.i60. View

12.

Azam M, Butler J, Duenes M, McAllister T, Walls R, Gianakos A . Advances in Cartilage Repair. Orthop Clin North Am. 2023; 54(2):227-236. DOI: 10.1016/j.ocl.2022.11.007. View

13.

Kennedy J, Murawski C . The Treatment of Osteochondral Lesions of the Talus with Autologous Osteochondral Transplantation and Bone Marrow Aspirate Concentrate: Surgical Technique. Cartilage. 2015; 2(4):327-36. PMC: 4297142. DOI: 10.1177/1947603511400726. View

14.

OBrien K, Tailor P, Leonard C, DiFrancesco L, Hart D, Matyas J . Enumeration and Localization of Mesenchymal Progenitor Cells and Macrophages in Synovium from Normal Individuals and Patients with Pre-Osteoarthritis or Clinically Diagnosed Osteoarthritis. Int J Mol Sci. 2017; 18(4). PMC: 5412358. DOI: 10.3390/ijms18040774. View

15.

Gabay C, Lamacchia C, Palmer G . IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol. 2010; 6(4):232-41. DOI: 10.1038/nrrheum.2010.4. View

16.

Dinarello C, van der Meer J . Treating inflammation by blocking interleukin-1 in humans. Semin Immunol. 2013; 25(6):469-84. PMC: 3953875. DOI: 10.1016/j.smim.2013.10.008. View

17.

Zhang G, Yang L, Han Y, Niu H, Yan L, Shao Z . Abnormal Macrophage Polarization in Patients with Myelodysplastic Syndrome. Mediators Inflamm. 2021; 2021:9913382. PMC: 8286189. DOI: 10.1155/2021/9913382. View